Amprion is a biotech company that focuses on the diagnosis for brain diseases.
AMPRION has raised $6.0M in total funding. The most recent round was Series B. The last funding was announced in September 2024.
AMPRION's investors include Eli Lilly, Propel(X), ALS Network, Formation Venture Engineering.
AMPRION is headquartered in San Francisco, United States.
Amprion is a biotech company that focuses on the diagnosis for brain diseases.
AMPRION is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AMPRION — Funding & Investors." VCBacked, September 25, 2024, https://www.vcbacked.co/company/amprion. Accessed July 30, 2026.
VCBacked. (2024). AMPRION — Funding & Investors. Retrieved July 30, 2026, from https://www.vcbacked.co/company/amprion
{{cite web |title=AMPRION — Funding & Investors |url=https://www.vcbacked.co/company/amprion |website=VCBacked |access-date=July 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated